We are looking to do this testing for patients who do not typically respond to treatment with rituximab. Although there are several reasons why rituximab would not work, Fcgamma receptor IIIA polymorphism is one of them. Could anyone provide any details on where we can get the testing done, clinically or on a research basic? Thank you